Warning: fopen(/home/virtual/jptm/journal/upload/ip_log/ip_log_2022-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Journal of Pathology and Translational Medicine
Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Pathol Transl Med > Volume 31(3); 1997 > Article
Original Article The Effect of Bacterial Lipopolysaccharide on the Lymphokine Production of the T Lymphocytes.
Hyung Bae Moon, Ki Jung Yun, Won Chul Han, Chae Woong Lim, Hyuk Nyun Kwon, Young Soon Park
Journal of Pathology and Translational Medicine 1997;31(3):244-251
DOI: https://doi.org/
  • 1,323 Views
  • 10 Download
  • 0 Crossref
  • 0 Scopus
1Department of Pathology, School of Medicine, Wonkwang University, Iksan 570-749, Korea.
2College of Veterinary Medicine, Chonbuk National University, Chunju 560-180, Korea.
3Department of Molecular Biology, College of Natural Science, Wonkwang University, Iksan 570-749, Korea.

It is well known that the murine T helper cell clones are divided by their lymphokine secretory activities. One is the Th-1 cell, producing IL-2 and IFN after stimulation and the other is the Th-2 cell, producing the IL-4 and IL-5. This study was undertaken to evaluate the immunomodulatory properties of the bacterial lipopolysaccharide(LPS) on the lymphokine production in vivo and in vitro. The results were as follows: There were no effects on the lymphokine secretion by the in vitro treatment of the LPS. The in vivo treatment of the LPS decreases the capability of the production of IL-2 and IFN , whereas it increases the capability of IL-4 production. The altered capacity of the lymphokine production was recovered about 2 weeks after the treatment of the LPS. There were no differences on the lymphokine production between E-coli LPS and salmonella LPS. The capacity of the lymphokine production was the same in the treatment of a non-heated LPS or heated-LPS. The lymphokine production of the mice which were desensitized by the long term treatment of the LPS was not different from the control mice. The in vitro treatment of RU486 can block the alterations of the lymphokine production after the treatment of the LPS. In summary, one can tell that the LPS increases the secretion of the IL-4 through the endogenous secretion of the glucocorticoids.

Related articles

JPTM : Journal of Pathology and Translational Medicine